Continue your journey online

In today’s globalized economy, international integration plays a crucial role in the development of new molecules. This integration encompasses various aspects, including the transfer of production activities and the utilization of past experiences. • Risk and Innovation: The development of APIs (active...

Despite the frequent claims that collaboration is the key to sustainability, very little proactive collaboration is apparent. This presentation will detail how true collaboration and action is possible, and how an Industry as a whole can deliver change and mobilise towards improved End of Life for its pac...

To improve pharmaceutical supply chain sustainability, it is crucial to place green chemistry and low-carbon technologies, including but not limited to continuous flow chemistry, and biocatalysis, at the forefront of the industry’s sustainability efforts. PharmaBlock's award-winning projects, recognized by...

Oncology has always been a powerhouse of innovation in healthcare, and with ground-breaking new technologies on the horizon, its impact is only set to continue. This dynamic session will go deep into growth areas within Oncology and evaluate the future pipeline and its implications in: • Elevating pati...

Understand the potential of the microbiome in shaping the future of therapeutics. Dive into the latest technological innovations propelling microbiome research forward, uncovering new insights and possibilities. • Discover the latest research findings with the microbiome • Exploring microbiome infl...

Strengthen your supply chain! Craft guiding principles for diversity and action-oriented collaboration at our "Credos for Powerful Partnerships • • Supplier Diversity: Building a strong network of diverse suppliers fosters innovation and resilience. • • Action Orientation in Supplier-Custome...

Testing for Mycoplasma is essential to ensure safety of biopharmaceutical products. With over 200 recognized species, Mycoplasmas are common contaminants in manufacturing facilities and cell-derived biologics. Existing compendial methods are complex and lengthy. PCR-based methods, while faster, can be limi...

Effective viral clearance processes during biologics manufacturing are the final shield to ensure product and patient safety. One of the classical methods for viral inactivation (VI) is the detergent treatment step in manufacturing of various drug modalities, including antibodies, plasma-derived products a...

Pharma thrives on innovation but requires strict regulations for safe and effective drugs. In today's age, navigating compliance for complex new technologies, drug manufacturing and patient safety adds to the challenge. • How compliance management systems such as digital documentation can reduce error...

Understanding how excipient quality affects drug performance and stability • Exploring the differences between excipient grades and their implications for formulation • Strategies for ensuring consistent access to high-quality excipients Selecting the optimal excipient grade for targeted drug delivery.

The drug delivery market is experiencing a significant transformation due to the need to reduce patient care costs, especially with the growing number of people dealing with chronic diseases. The aim of transitioning to self-administered medications at home, while also remotely monitoring patient complianc...

KBI Biopharma’s cell line development services, powered by Selexis®, have been at the forefront of innovation for the last two decades. We are introducing the latest version of proprietary SURE CHO-M technology, which uses a transposase-based semi-targeted integration method and provides high productivity ...

Join our panel of experts, where we delve into the new frontier in formulation development and how the pharma ecosystem in the Middle East are looking to shape next-generation development

Hear about the future of pharma from its current young leaders. Join this session featuring our Future Leader Award nominees as they share their insights on the industry's future and discuss strategies to cultivate the next generation of leaders. Discover how these young visionaries are driving change and ...

Join us as we delve into the transformative potential of personalized medicine in shaping smart drug delivery systems. Gain insights on the latest in patient-specific data and innovative technologies to tailor drug delivery for individual patients.
• Key topics include:
• How AI can analys...

In the rapidly evolving landscape of pharmaceutical manufacturing, the TT&GO® platform by Suanfarma CDMO stands out as a revolutionary solution for technology transfer. This session will explore into the unique methodology of TT&GO®, which integrates rigorous, systematic procedures grounded in risk-based a...

The recent acquisition of Catalent is driving significant transformation in the CDMO space within the pharmaceutical landscape. This shift has led CDMOs to expand beyond manufacturing, incorporating development services into their offerings. This evolution is redefining their role in the supply chain, prov...

Africa stands at the cusp of unprecedented growth, offering a wealth of opportunities for strategic partnerships and investment.  Unprecedented momentum in catalytic initiatives for ecosystem development offer potential for unlocking aggregate commercial opportunity greater than $20Bn.  By fostering collab...

Join our session on safeguarding the supply chain, where we'll discuss strategies for identifying and managing disruption triggers, implementing strategic mapping and monitoring to prevent bottlenecks, and staying ahead of future disruptions through proactive forecasting.

The world’s leading pharmaceutical and healthcare companies are collaborating to reduce scope 3 emissions. Energize, a first-of-its-kind program, is designed to accelerate the adoption of renewable electricity aimed to decarbonize the pharmaceutical and healthcare global supply chain. In partnership with S...

The Science-Based Targets initiative (SBTi) translates compliance to the limitation of global warming to 1.5°C as per the Paris Agreement to the requirement to decarbonise Scope 1 and 2 emissions by 90%. This necessitates not just an adjustment of current operational strategies, but a fundamental rethinkin...

GMP principles in pharmaceutical ingredient manufacturing for ensuring consistent quality and safety • Overview of auditing processes, including planning, execution, reporting, and follow-up actions, to ensure compliance and drive continuous improvement • Comparative analysis of regulatory frameworks...

Green chemistry and engineering offer a path to sustainable processes, materials, and products that align with the UN Sustainable Development Goals. In pharmaceuticals, a significant portion of the environmental impact, especially carbon footprint, comes from producing Active Pharmaceutical Ingredients (AP...

In pharmaceutical manufacturing, operational efficiency is crucial for meeting production targets while ensuring product quality and reducing manufacturing cost. One impactful strategy is increasing the number of cavities per nest for prefilable polymer syringes. This enhancement maximizes conveyor space u...

In this interview from CPHI Milan, hear from LX Pantos CEO, Young-ho Lee on the rapid growth of pharma logistics in healthcare services, LX Pantos' take on ESG services in the industry today, how the company utilises CPHI, and their plans for the future of pharma logistics.

Join our panel of experts as they will examine the differences between clinical and commercial packaging in the pharmaceutical industry. Key topics include scaling up from clinical trials to commercial production, complying with global regulations, and ensuring patient safety and efficient supply chains. A...

In biologics production, mixing operations are crucial for maintaining fluid homogeneity. However, shear stress during mixing can affect protein stability and quality attributes. Understanding how mixer design and process parameters influence shear force generation is essential for product integrity. Co...

The evolving landscape of the pharmaceutical industry, marked by significant breakthroughs in advanced treatments and relentless pressures for speed and innovation, has fundamentally transformed the role of Contract Development and Manufacturing Organizations (CDMOs). As the industry faces challenges from ...

Andrea Robbiani, Business Development Executive for Smart Manufacturing, highlights innovative technologies and solutions aimed at optimising processes and driving efficiency in the pharmaceutical industry, presented at CPHI Milan.

Advantages of glass packaging • Why glass packaging has long term sustainability benefits • Assessing the security measure glass packaging brings to traditional packaging and how it improves security and patient safety

Biosimilars are delivering on their cost-saving potential, reducing biologic medication costs and expanding treatment options. However, there are hurdles that hinder optimal biosimilar use, potentially jeopardizing their long-term viability in the healthcare system. Examining these challenges through real...

Join our panel as we delve into the role of Critical Medicines Alliance (CMA) initiative that was set by the European Commission. The CMA serves as a consultative platform that unites relevant stakeholders from EU Member States, with its objective is to pinpoint essential areas and priorities for action, o...

Discover how digital health is transforming the pharmaceutical industry. Explore the expanding role of technology across the pharma value chain and its implications for the future

Highlighting common worker safety challenges and opportunities in HPAPI production • What practices are required to ensure that workers are protected from highly potent toxins • Why its essential to maintain initiatives in product quality, regulations and continuous improvement to help safeguard pati...

Join our opening keynote session as we delve into the understanding of what is behind the buzz word of sustainability in the context of the pharmaceutical industry. • • In an interactive manner, we’ll assess what our sustainability priorities are. and compare the state of sustainability integration...

What does the publication process look like? • How to prepare a manuscript • Ethical considerations during the publication process • Identifying the target journal • Peer review do’s and don’ts • How we can help you enhance your research through our services

• China DMF Regulatory Framework • China DMF Pathways • Comparison between China DMF, US DMF, EU CEP and ASMF • China DMF requirements, timelines and costs • Tips & Pitfalls

This session will delve into the major challenges the pharmaceutical industry encounters in managing Scope 3 emissions, which make up the bulk of its carbon footprint. It will examine why these emissions are especially difficult to control due to the complexities within the value chain. • • Addition...

Delve into the future of vaccination technology as market experts Moderna unveil the potential of mRNA vaccines to revolutionise healthcare. Don't miss this opportunity to explore the forefront of medical innovation and discover how these next-generation vaccines are reshaping the landscape of disease pre...

As a Contract Development and Manufacturing Organization (CDMO), navigating the landscape of EU API manufacturing presents critical challenges and opportunities. In response to Cefic’s November 2023 recommendations, CDMOs have an important role to play to foster sustainable growth, support reshoring initia...

Discover highly bioavailable liposomal iron, Liposovit®-Fe • Join us to: • • Understand Iron Deficiency: • o Learn about the global impact and at-risk groups for iron deficiency and anemia. • • Explore Liposovit®-Fe: • o Discover the benefits of Liposovit®-Fe’s advanced liposomal technology....

In this exclusive interview, Hari K. Chereddi, CEO of HRV Global LifeSciences and NHG Pharma, shares the inspiring story behind the companies, their vision and mission, and how they stand out in the competitive pharmaceutical and healthcare markets. He delves into their innovative approaches to market expa...

The purpose of this section, is to give to the audience some advice and warnings on how to better develop and produce a customized drug delivery medical device, based on our own experience. in fact the pathway for a new drug delivery medical device, is full of the unexpected and sometimes the company has t...

In this presentation, we introduce our most recent development – a versatile, reusable, and connected electromechanical solution that upholds the concept of drug agnosticism, platform flexibility, ease-of-use, as well as device programmability. By leveraging technological application expertise, we demonstr...

The global gummy vitamin market is expected to reach 10.6 billion by 2025 and gummies are gaining traction as a drug delivery system -- especially for children and seniors who resist taking pills, capsules and liquids. Mitchell Slade, who brings more than 20 years of gummy manufacturing experience at Natur...

This session dives into the critical stages of technology transfer, exploring key factors that empower manufacturers to streamline biologics production and ensure timely delivery of these life-saving therapies. • How timely tech transfer can increase regulatory adherence • Success factors for optimal...

In this insightful session, we explore how pharmaceutical companies integrate advocacy projects into their marketing strategies to address growing scrutiny and the demand for transparency and social responsibility. By examining a case study with Merck, we will demonstrate how these initiatives not only pos...

Bio-manufacturing is rapidly evolving with increased outsourcing, new modalities, and M&A opportunities shaping the landscape. • Join our panel of experts and explore the latest in outsourcing trends, partnership models, and the M&A activity that is fostering growth, capacity and capabilities.. • ...

Ensuring you can answer the following 3 questions - What do you want? How much do you want? When do you want it? • Highlighting the common mistakes that are made and how you can avoid them • Assessing the tools at your disposal to ensure you choose the right partner

Even though it should be considered part of our everyday business, is it standard for multimodal CDMOs to truly operate with a holistic quality mindset, prioritizing the health and safety of both workers and patients? At FUJIFILM Diosynth Biotechnologies, quality and safety are two sides of the same coin...

Cell-cultured meat production is increasing, predicting to reach $1.1 billion in value by 2034. Though not the usual modality, various companies in the life science industry have expanded their interest and activity to cell-cultured meat research and manufacturing because of the similarity in equipment and...

Creating impact requires clarity of the problem you intend to solve. • • Join us for a focused session exploring the emission drivers behind different drug delivery methods like tablets, inhalers, and injectables. Harmonized parallel assessment helps you to understand commonalities and differences ...

SÜDPACK MEDICA’s PharmaGuard® is recognized as one of the leading polyolefin blister packaging solutions, rewarded with the Worldstar Global Packaging Award 2024 in the Medical and Pharmaceutical category, and the ‘Prestigious German Packaging Award’ (Deutscher Verpackungspreis) in the sustainability categ...

• Consumer Empowerment: Unpacking the role of smart labels in enabling instant product authentication by consumers, thus fostering greater confidence and safety in pharmaceutical products. • Multi-dimensional Benefits: Examining the broader benefits of smart label technology beyond anti-counterfeitin...

During the interview Andrey Zaikin, Head of Sourcing and Growth Strategy at Zentiva answered the following questions: • Andrey, you are Head of Sourcing and Growth strategy? Why are you coming to CPHI? • How many partners are you meeting here? Do you expect any new business initiated here? • What ...

Using case studies from Anthesis’s work supporting pharmaceutical industry to reduce the impact of medicinal packaging, this talk will present our insights into the benefits and potential pitfalls of different materials and innovations. Through the application of life cycle assessments, we will guide you t...

Biopharmaceutical development and production requires the investment of significant time and resources. Manufacturing procedures must be efficient, robust and productive to minimize failure risk and ensure targets are met. • With increasing product titers, greater volumes of process buffer are required...

The role of nutraceuticals in healthcare is growing in prominence and R&D is fueling innovation across the sector to enhance the safety and therapeutic value of dietary supplements and nutraceuticals. • Why tapping into the consumer market can help manage current delivery expectations; • How can cu...

Dr Jing Li, President; Senior VP of Process Chemistry of PharmaBlock (USA) Inc., speaks in an interview from CPHI Milan 2024 on their recent win for the ACS Green Chemistry Award. PharmaBlock is invested in innovation for sustainability, PharmaBlock has a strong vision to drive the sustainable developm...

The European Union faces a growing challenge in securing its supply of essential pharmaceuticals. Currently, the majority of its active pharmaceutical ingredients (APIs) and finished medicines are imported from Asia, with China being the largest single supplier. This heavy reliance on external sources has ...

Clinical Approaches in Type 2 diabetes, Weight loss, and Fatty Liver Disease(NASH)

Traditional biologics manufacturing relies on batch processing, which involves sequential operations and faces significant limitations, such as low productivity, lengthy processing times, and high operational costs due to large infrastructure needs and frequent manual interventions. To overcome these chall...

Gai Liu, Director at Gan & Lee Pharmaceuticals, shares the company’s remarkable journey, highlighting key milestones, their diverse product portfolio, and ongoing research initiatives. The interview also provides insights into Gan & Lee's international expansion strategies, talent development, and innovati...

Join us on October 9th at 14.15 to discover how you can revolutionize your operations, and maximize efficiency with Akkodis' AI-powered solutions for the Life Sciences & Healthcare industry. Our presentation, "Optimize Total Cost of Ownership in Life Sciences & Healthcare" will unveil cutting-edge strategi...

A talk with a cyber security professional, sharing valuable insights gained from a career in the UK intelligence community. A look at the potential threats that the pharmaceutical industry faces and how risks can be mitigated. Including an introduction to the complexities of using AI securely.

Join us on day 2, into the potential of biosimilars to expand access to critical treatments for patients. • We'll explore how these medications can play a significant role in healthcare, while also discussing the opportunities and challenges associated with their wider adoption.

Natural products can be characterized by complex structure, limited availability, and exceptional potency, whose combination makes it challenging their development as API. Success requires integration of expertise in different areas, including the construction of a sustainable supply chain for the startin...

Holger Krenz will be speaking at CPHI Milan about Gerresheimer’s platform solutions for primary packaging and drug delivery systems. His presentation will focus on the product benefits of the Gx Elite performance level which are the ideal packaging components for reliable functionality of drug delivery sys...

Pharma is often perceived as lacking innovation outside its core R&D operations. However, the venture capital arms of major pharmaceutical companies play a crucial role in driving innovation and tackling significant healthcare challenges. Join this panel discussion to gain the latest insights into the curr...

In this interview from CPHI Milan, Chris Peti the CEO of Jubilant HollisterStier shares insights into their capabilities, the details of their recent facility expansions, including Lines 3 and 4 at their Spokane facility, and the vision driving this growth. They also explain how potential partners can conn...

Join us as we explore the role sustainability professionals within organizations to shape and drive the sustainability ambition and agenda. Discover how sustainability professionals—from leaders to cross-functional teams—are shaping a culture of environmental responsibility, streamlining actions towards ne...

Explore Lonza new innovation center, dedicated to accelerating capsule development for oral and pulmonary drug delivery. Join us to discover how we foster collaboration with customers and co-innovation in a cutting-edge environment where science meets ingenuity. Learn how our expert team tackles complex fo...

Pharmacovigilance is not limited to adverse event reporting. Safety data reporting is the first step for detection and mitigation of new drug- related risks, identification of new opportunities to improve medicine and device safety profiles to ensure consumer safety worldwide, guarantee compliance with glo...

Big Pharma reports that up to over 90% of their CO2 emissions are scope 3. This is not only a huge burden but also the most difficult part to influence for pharmaceutical industry. However, there are ways to manage and collaborate in the industry. Christophe Marie from Aptar Group will highlight how Aptar ...

As biopharma companies increasingly seek to optimize the drug development timeline, China has emerged as a cost-effective biomanufacturing hub for both the rapidly growing Chinese market and the rest of the world. New localization guidelines set by the NMPA’s Center for Drug Evaluation encourage global com...

Diversity and inclusion can be fostered in different spheres of influence within the pharma industry and with varying results. This inspiring session aims to shed light on many of these critical points of view. Join us to gain firsthand insights from our distinguished panel of experienced leaders – (CEOs, ...

The triple bottom line demands that people, planet, and profit converge. Profit remains a central focus of enterprises and often is in conflict with the others two pillars. Finding the right business model is crucial to enable sustainability efforts to become a business instead of a cost case. • • ...

The purpose of this section, is to give to the audience some advice and warnings on how to better develop and produce a customized drug delivery medical device, based on our own experience. in fact the pathway for a new drug delivery medical device, is full of the unexpected and sometimes the company has t...

Digital transformation is becoming an essential part of biopharma manufacturing as it helps improve product quality and robustness. Join our panel of experts where we • Exploring the power of digital technologies for real-time monitoring and quality enhancement in manufacturing • Unveiling AI's expa...

Join our opening keynote and gain insights into emerging trends, sustainability initiatives, and the transformative potential of Industry 5.0. This session will explore what the future looks like for pharma manufacturing.

There are two major themes that involve primary packaging components in the revised EU GMP Annex 1 issued in August 2023. This recent revision includes: • Implementing a holistic Contamination Control Strategy (CCS) • Container Closure Integrity (CCI) because a properly seated stopper represents a...

Understanding Nitrosamines: Exploring the presence, formation, and risks associated with nitrosamines in pharmaceuticals. • Developing proactive strategies to mitigate nitrosamine risks throughout the supply chain. • Implementing safety components and protocols to prevent nitrosamine contamination i...

The global alert on nitrosamines has profoundly impacted the pharmaceutical industry, necessitating an immediate and comprehensive response from all stakeholders involved. Nitrosamines, which are classified as probable human carcinogens, have historically been associated with the consumption of cured meats...

Today’s practice of single-use plastic packaging in pharma industry is a waste and emission driver consuming finite resources. As of today, virgin material is applied to ensure patient safety resulting in large quantities of waste. Three pharma pioneers addressed this issue led by the question: How to over...

Looking at examples of challenges and bottlenecks in cell therapy applications and what can be done to overcome them • Assess automation and process optimization tools and its role in scaling up cell therapy production

Existing and upcoming trends for plant-based extracts represent a challenge for softgel manufacturers – as potential extreme crosslinking components. • With RXL® Ultra, GELITA re-focusses on an established, but hidden/un-noticed, solution to conquer these crosslinking challenges. As part of the RXL®-pro...

The European Commission published a communication launching the EU Biotech and Biomanufacturing Initiative to enhance competitiveness and industrial modernization. These efforts seek to foster innovation, facilitate investment, and position the EU as a leading hub for biotechnology and biomanufacturing. ...

Join our Pharma Awards Winner as we Recognise their achievements in accelerating innovation and improving patient outcomes across healthcare

During pharmaceutical product development, Boehringer Ingelheim generates hundreds of thousands of documents, each containing valuable knowledge and problem-solving strategies. • The challenge is to make this knowledge accessible within the company to avoid redundant efforts. To address this, Boehrin...

Ensure highest product quality and lowest cosmetic defects • Accelerate drug development by most comprehensive data packages • Create tailored system options with state-of-the-art technologies and components • Offer best fit for demanding drug formulations by addressing bio-pharmaceutical require...

A new drug substance and drug product production route using integrated continuous manufacturing has been developed for a Roche drug. This new manufacturing process successfully addresses supply chain constraints and patient needs, reducing the lead time from 15 months down to 50 hours. • Equivalent yi...

The session will focus on exploring actionable strategies to harness opportunities in the biosimilars and generics market in advancing global health outcomes. Biosimilars are the next wave in the healthcare landscape to meet the unmet needs of patient care and generics continue to improve access by contrib...

During the interview, Petra Valentova, Head of Prague Scientific at Zentiva answers the following questions: • Is this the first time that you’ve visited the event? • As a Head of Prague Scientific, would you tell us something more about it? • What is your agenda looking like for the rest of CPHI?

Aptar Pharma's presentation entitled "Innovations in Inhalation" explores the current extensive portfolio of high-quality OINDP (Orally Inhaled and Nasal Drug Products) delivery devices. The presentation also highlights Aptar Pharma's comprehensive services which support respiratory drug development, inclu...

Drug formulations are changing, and the share of subcutaneous administration over intravenous infusion is increasing. Subcutaneous administration is seen to be the preferred approach both by patient and healthcare providers. • Careful consideration is required when selecting a sterilizing grade filter ...

The pharmaceutical sector is dedicated to caring for and improving the well-being of others, yet we often overlook the well-being of those working within the industry. This session offers a break from the hustle and bustle of the show floor, providing an opportunity to explore key areas for personal and pr...

Discover how single-use technologies are driving advancements in biopharmaceutical manufacturing. • Exploring the advantages: Delve into the benefits of utilizing single-use technologies in biologics manufacturing, including increased flexibility, reduced contamination risks, and enhanced scalability....

In the rapidly evolving pharma industry, digital transformation is no longer a mere buzzword—it's an imperative. For drug development, market entry and business development, this shift involves more than just adopting new technologies; it requires a fundamental change in how companies engage with patients,...

Gain new insights into nucleotides through groundbreaking clinical trials conducted on Nerviplex and Nerviplex Forte, two pharmaceutical formulations designed to address peripheral neuropathies. These placebo-controlled, double-blind studies adhere to rigorous drug-like protocols, ensuring robust results i...

The absence of a compelling business case is a key barrier to net-zero transformation of the pharma ecosystem. This panel discussion focusses on how this barrier can be overcome by adjusting the business model and organizational concepts. • • Join this session and get inspiration on how to translat...

• OXYCAPT Multilayer Plastic Vials with high O2 and CO2 barrier • 20-times superior O2 and CO2 barrier than COP • Prevent CO2 ingress generated from dry ices and stabilize drug’s pH level • Excellent container closure integrity (CCI) at deep-cold and cryogenic temperature • Very high impact st...

Explore the use of digital twin technology to simulate pharma manufacturing processes, allowing for optimization of processes, scale up, faster validation and training for faster to market and without risking actual production and quality. We scratch the surface of what it takes in respect to digital ...

Join our panel of experts as we delve into the latest innovations and advancements in academia, exploring how these developments can benefit the biologics industry.

Director Jeong Min Choi discusses the advancements and strategies behind Korean companies' push to commercialise biopharmaceutical raw materials on a global scale, highlighting innovation, collaboration, and future growth opportunities in this rapidly evolving industry.

Jan Kengelbach, CEO of Aenova, discusses how the company’s partnership with Kühne Holding AG, its focus on capacity, innovation, and flexibility, and its strategic growth plans position it as a leading partner in the CDMO sector. He also shares insights on Aenova’s approach to evolving industry trends and ...

Developing purification protocols can be challenging for molecules beyond traditional mAbs such as bispecific antibodies, antibody fragments, and other recombinant proteins. Here we cover strategies to help simplify purification of some of these trickier molecules. This presentation covers: • Aspects o...

Join our session on navigating outsourcing partnerships for start-ups, where we'll explore effective strategies and best practices for collaborating with external partners to accelerate growth and innovation. Learn how to leverage outsourcing to optimize resources and drive success in your startup journey

Ensuring accurate potency testing and maintaining product purity are crucial in antibody-drug conjugate (ADC) development, scale-up, and commercialization. Innovative solutions, including effective tools and streamlined processes, are necessary for efficient production of ADCs for clinical trials and comme...

Fujifilm has been in the healthcare business since the early days of its 90-year history. Today, we provide CDMO services to help our partners develop innovative medicines in the field of biopharmaceuticals. • In the field of lipid-nanoparticles (LNPs), Fujifilm's team of synthetic chemists has develope...

With the packaging market poised for significant growth in the next decades, CPHI Milan's opening keynote will explore the key drivers fuelling this expansion. From the rapid evolution of drug delivery systems to the surge in generic drug consumption and the industry's continuous innovation, discover the f...